Literature DB >> 12620799

Chromatin repression by COUP-TFII and HDAC dominates activation by NF-kappaB in regulating major histocompatibility complex class I transcription in adenovirus tumorigenic cells.

Biwei Zhao1, Shihe Hou, Robert P Ricciardi.   

Abstract

In adenovirus type 12 transformed cells, the down-regulation of MHC class I transcription contributes to the tumorigenic phenotype and is solely mediated by Ad12 E1A. Previous in vitro studies with class I enhancer sequences have indicated that there is an increased binding of repressor COUP-TFII and its associated HDAC and a decreased binding of activator NF-kappaB. In this study, we used chromatin immunoprecipitation (ChIP) assay in order to determine in vivo whether these proteins regulate class I transcription by affecting chromatin. The ChIP assay revealed that there is lack of chromatin histone acetylation in the region of the class I enhancer in Ad12-transformed cells. This is regulated by histone deacetylation as it was further demonstrated in vivo that COUP-TFII and HDAC are associated with the class I enhancer chromatin. In agreement with in vitro studies, NF-kappaB could be recruited to the class I enhancer following induction by TNF-alpha. However, this enhancer-bound NF-kappaB failed to up-regulate class I expression because the class I enhancer chromatin remained repressed as a result of histone deacetylation by HDAC in association with COUP-TFII. Thus, we have demonstrated for the first time that repression of chromatin through histone deacetylation is a major mechanism in down-regulating class I transcription in Ad12-transformed cells. Finally, Ad12 E1A, a non-DNA binding protein, was shown to be present in the natural protein complex bound to the class I enhancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620799     DOI: 10.1016/s0042-6822(02)00079-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

2.  Induction of neuronal and tumor-related genes by adenovirus type 12 E1A.

Authors:  Hancheng Guan; Jim F Williams; Robert P Ricciardi
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  Tumorigenic adenovirus type 12 E1A inhibits phosphorylation of NF-kappaB by PKAc, causing loss of DNA binding and transactivation.

Authors:  Hancheng Guan; Junfang Jiao; Robert P Ricciardi
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.

Authors:  A Nazmul H Khan; Christopher J Gregorie; Thomas B Tomasi
Journal:  Cancer Immunol Immunother       Date:  2007-11-28       Impact factor: 6.968

Review 5.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Authors:  Devin Dersh; Jaroslav Hollý; Jonathan W Yewdell
Journal:  Nat Rev Immunol       Date:  2020-08-20       Impact factor: 53.106

6.  The PPE2 protein of Mycobacterium tuberculosis translocates to host nucleus and inhibits nitric oxide production.

Authors:  Khalid Hussain Bhat; Shruti Srivastava; Sandeep Kumar Kotturu; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

7.  Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells.

Authors:  Tao Zhang; Xiao-Hang Li; Dian-Bao Zhang; Xiao-Yu Liu; Feng Zhao; Xue-Wen Lin; Rui Wang; Hong-Xin Lang; Xi-Ning Pang
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-23       Impact factor: 8.886

8.  Role of gene methylation in antitumor immune response: implication for tumor progression.

Authors:  Alfonso Serrano; Isabel Castro-Vega; Maximino Redondo
Journal:  Cancers (Basel)       Date:  2011-03-29       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.